STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,502 | -48.8% | 28,300 | +38.0% | 0.00% | -100.0% |
| Q2 2023 | $217,915 | +53.9% | 20,500 | +20.6% | 0.00% | – |
| Q1 2023 | $141,610 | -29.5% | 17,000 | -21.9% | 0.00% | -100.0% |
| Q4 2022 | $200,789 | -58.6% | 21,754 | -42.4% | 0.00% | -50.0% |
| Q3 2022 | $485,000 | +129.9% | 37,744 | +135.9% | 0.00% | +100.0% |
| Q2 2022 | $211,000 | -11.0% | 16,003 | +42.4% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | -56.1% | 11,242 | -50.1% | 0.00% | 0.0% |
| Q4 2021 | $540,000 | -73.6% | 22,527 | -72.0% | 0.00% | -80.0% |
| Q3 2021 | $2,049,000 | -42.5% | 80,549 | -23.9% | 0.01% | -37.5% |
| Q2 2021 | $3,565,000 | -27.9% | 105,914 | -16.8% | 0.01% | -38.5% |
| Q1 2021 | $4,947,000 | +220.2% | 127,366 | +410.7% | 0.01% | +225.0% |
| Q4 2020 | $1,545,000 | – | 24,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |